Table 21-6.
Quality Metrics | Overall | STEMI | NSTEMI |
---|---|---|---|
ECG within 10 min of arrival | 61 | 73 | 55 |
Aspirin within 24 h of arrival | 97 | 98 | 96 |
Any anticoagulant use* | 93 | 95 | 91 |
Dosing error | |||
UFH dose | 54 | 55 | 54 |
Enoxaparin dose | 12 | 12 | 12 |
GP IIb/IIIa inhibitor dose | 8 | 8 | 8 |
ADP receptor inhibitor† on discharge | 82 | 93 | 74 |
Prescribed statins on discharge | 92 | 95 | 90 |
Adult smoking cessation advice/counseling | 98 | 99 | 98 |
Cardiac rehabilitation referral | 75 | 82 | 70 |
In-hospital mortality‡ (95% CI) | 4.8 (4.6–4.9) | 5.9 (5.7–6.2) | 4 (3.8–4.1) |
ACTION-GWTG indicates Acute Coronary Treatment and Intervention Outcomes Registry–Get With The Guidelines; ACS, acute coronary syndrome; STEMI, ST-segment elevation myocardial infarction; NSTEMI, non–ST-segment elevation myocardial infarction; UFH, unfractionated heparin; GP, glycoprotein; ADP, adenosine diphosphate; and CI, confidence interval.
Values are percentages.
Includes UFH, low-molecular-weight heparin, bivalirudin, or fondaparinux use.
Includes clopidogrel or prasugrel.
Excludes transfer-out patients.